Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Corcept Therapeutics Incorporated (CORT) had Receiveable Turnover of 3.33 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$256.15M |
|
$42.14M |
|
$4.06M |
|
$252.09M |
|
$214.85M |
|
$41.30M |
|
$4.63M |
|
$45.93M |
|
$45.93M |
|
$42.99M |
|
$42.99M |
|
$42.99M |
|
$42.99M |
|
$41.30M |
|
$42.16M |
|
105.38M |
|
118.39M |
|
$0.40 |
|
$0.36 |
|
| Balance Sheet Financials | |
$439.68M |
|
$5.13M |
|
$449.03M |
|
$888.70M |
|
$153.80M |
|
-- |
|
$29.12M |
|
$182.93M |
|
$705.78M |
|
$705.78M |
|
$705.78M |
|
107.92M |
|
| Cash Flow Statement Financials | |
$16.77M |
|
$-24.70M |
|
$-1.28M |
|
$121.75M |
|
$112.29M |
|
$-9.46M |
|
$52.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.86 |
|
-- |
|
-- |
|
-- |
|
-- |
|
98.41% |
|
16.12% |
|
16.12% |
|
-- |
|
17.93% |
|
16.45% |
|
$14.04M |
|
-- |
|
-- |
|
-- |
|
0.29 |
|
0.31 |
|
|
Receiveable Turnover |
3.33 |
27.03 |
|
6.09% |
|
6.09% |
|
4.84% |
|
6.09% |
|
$6.54 |
|
$0.12 |
|
$0.14 |
|